LAWRENCE BURSTEIN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Protagenic Therapeutics, Inc.\new

Filing Date Source Excerpt
2009-05-26 Lawrence Burstein 66 Director
2010-10-25 Includes 14,033 shares of Common Stock and 76,050 shares of Common Stock issuable upon the exercise of options held by Mr. Burstein.

Data sourced from SEC filings. Last updated: 2026-03-05